Clinical Performance and Safety of ENDOPACK® DT4-EBMCA in ACL Reconstruction 24 Months Post-surgery

Inclusion criteria

• Patient implanted with DT4-EBMCA in Médipôle Garonne for a total or partial rupture of the anterior cruciate ligaments
• Patient having answer to IKDC and KOOS pre-operative
• Patient having received information and signed informed consent

Exclusion criteria

• Patients who refuse to participate
• Patients unable to understand questionnaires
• Patients who, at the time of surgery, present the contraindications and Factors likely to jeopardize the success of the implant contained in the IFU :
• Acute or chronic, local or systemic infections;
• Severe muscular, neurological or vascular impairments affecting the extremity concerned;
• Bone destruction or poor bone quality that may affect device stability;
• Any concomitant condition that may affect device function;
• Patients with sensitivity to device material that may cause allergic reactions.
• Severe osteoporosis;
• Significant deformity, congenital dislocation;
• Local bone tumours;
• Systemic or metabolic disorders;
• Infectious diseases;
• Substance abuse and/or tendencies to abuse drugs or medication;
• Obesity;
• Unsupervised intense physical activity.